| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/30/2005 | US20050143933 Analyzing and correcting biological assay data using a signal allocation model |
| 06/30/2005 | US20050143932 Meal planning tool |
| 06/30/2005 | US20050143931 System and methods for non-targeted processing of chromatographic data |
| 06/30/2005 | US20050143930 Method of acquiring a set of specific elements for discriminating sequence |
| 06/30/2005 | US20050143929 Protein engineering with analogous contact environments |
| 06/30/2005 | US20050143928 Method and apparatus for discovering patterns in binary or categorical data |
| 06/30/2005 | US20050143926 Method and apparatus for generating biologically-active-substance candidate structure, and computer product |
| 06/30/2005 | US20050143925 Safety test support system, method and program |
| 06/30/2005 | US20050143675 Integrated diagnostic test system |
| 06/30/2005 | US20050143628 Methods for characterizing tissue or organ condition or status |
| 06/30/2005 | US20050143602 free from recesses formed on an inner surface of a reactor body thereof so as to conduct a stable oxidation reaction therein; reaction production gas is prevented from being condensed and polymerized in the sampling tube, thereby ensuring a long-term stable analysis with a high efficiency |
| 06/30/2005 | US20050143472 Novel treatment for pathologies associated with oxidative damage |
| 06/30/2005 | US20050143467 Adjust fatty acid oxidation; stimulant carnitine palmitoly transferase |
| 06/30/2005 | US20050143403 Substituted pyrimidinones and pyrimidinthiones |
| 06/30/2005 | US20050143357 Vitamin d upregulated protein 1 (vdup-) methods and uses thereof |
| 06/30/2005 | US20050143334 Metastatic M-4A4 cell line and non-metastatic, but equally tumorogenic NM-2C5 cell line; therapeutic and diagnostic methods for cancer; matrix metalloproteinase-8, matrix metalloproteinase-17 |
| 06/30/2005 | US20050143311 A peptide fragment containing selenocysteine has a lowered toxicity than selenocystine, exhibits a cytotoxicity-inhibitory activity; screening a drug having cytotoxicity-inhibitory activity by utilizing a cellular sudden death phenomenon in a cell culture system; glutathione peroxidase activity |
| 06/30/2005 | US20050143308 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/30/2005 | US20050143307 Biological activity that prevents the binding of formyl methionine-leucine-phenylalanine (fMLP) and/or C5a protein to granulocytes; acute and chronic inflammation reactions and HIV infection |
| 06/30/2005 | US20050143306 Antigenic peptide fragments of growth differentiation factor 8, and related immunogens, vaccines; Immunization; drug screening |
| 06/30/2005 | US20050143295 Identification of genes found in particular brain regions of rats that are modulated by behavior associated with cocaine addiction and extinction training, GABA-B receptor subunit gb2, myelin-associated basic protein, calcitonin receptor, Bos taurus-like neuronal axonal protein, FRA-2, |
| 06/30/2005 | US20050143287 Ischemic heart disease, critical limb ischemia, wound healing and burns, cancer, diabetic retinopathy, and inflammatory diseases such as arthritis and psoriasis |
| 06/30/2005 | US20050143285 Fluorescence based screening assays are provided that allow for the for identification of agents that selectively bind to a ligand-gated ion channels (LGIC); fluorescence resonance energy transfer (FRET) |
| 06/30/2005 | US20050142666 Liquid microarray; for use as diagnostic tools |
| 06/30/2005 | US20050142664 providing vibrations comprising resonance frequencies, amplifying the vibration in response to the resonant frequency and modulating the resonant frequency, to cause the amplified vibration to generate turbulent flow in fluids that influences the interaction between targets molecule with probes arrays |
| 06/30/2005 | US20050142662 Phased micro analyzer VIII |
| 06/30/2005 | US20050142661 Determination of multi-valent metal contamination and system for removal of multi-valent metal contaminants from water |
| 06/30/2005 | US20050142655 Apparatus for use in analysis of genes; determining gene base sequences; genetic mapping |
| 06/30/2005 | US20050142640 MUC-1 derived peptides |
| 06/30/2005 | US20050142635 chimeric antibodies comprising variable domain peptides, DNA codes for the antibodies, expression vectors, host cells and a process of culturing the host cells to produce the monoclonal antibodies, used for immunotherapy; nonimmunogenic |
| 06/30/2005 | US20050142634 Novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof |
| 06/30/2005 | US20050142630 Interaction of NMDA receptor with the protein tyrosine phosphatase step in psychotic disorders |
| 06/30/2005 | US20050142628 Use |
| 06/30/2005 | US20050142627 measurement of cholesterols, triglycerides and phosphatides in blood using enzymes, in the presence of organic silicon compounds |
| 06/30/2005 | US20050142626 kits used for diagnosis of diseases in which activated eosinophils are present at the disease sites, the kits comprising reagents selected from isotope labeled 3-bromotyrosine, 3,5-dibromotyrosine, peptides and/or mixtures |
| 06/30/2005 | US20050142624 Chip and method for analyzing enzyme immunity |
| 06/30/2005 | US20050142622 using biosensor comprising solid supports attached to detectably labeled substrates specific for enzymes produced and/or secreted by bacteria |
| 06/30/2005 | US20050142621 Methods of identifying anti-cancer agents and uses thereof |
| 06/30/2005 | US20050142620 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/30/2005 | US20050142618 Method for diagnosing diseases based on levels of anti-glycan antibodies |
| 06/30/2005 | US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis |
| 06/30/2005 | US20050142616 Diagnostic test for neuropsychiatric systemic lupus erythematosus |
| 06/30/2005 | US20050142614 Methods for ligand discovery |
| 06/30/2005 | US20050142613 Test for the rapid evaluation of ischemic states and kits |
| 06/30/2005 | US20050142612 Inhibitors of amyloid precursor protein processing |
| 06/30/2005 | US20050142611 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 06/30/2005 | US20050142610 domains peptides having increased or decreased binding specificity for phosphatides, used as controls in bioassays to detect the presence of specific phosphatides |
| 06/30/2005 | US20050142609 Native immunoglobulin binding reagents and methods for making and using same |
| 06/30/2005 | US20050142608 Screening method and device, and new drug screening method and device |
| 06/30/2005 | US20050142607 Contacting biological sample with at least two antibodies wherein epitope in Moraxella catarrhalis for each antibody is either internal or surface exposed and detecting binding of antibodies to sample, wherein binding is indicative of presence of Moraxella catarrhalis; bacteria-induced acute otitis media |
| 06/30/2005 | US20050142606 Determination of ions using ion-sensitive enzymes |
| 06/30/2005 | US20050142605 Plasmon-enhanced marking of fragile materials and other applications thereof |
| 06/30/2005 | US20050142604 Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2210 |
| 06/30/2005 | US20050142599 Robust genotyping method using DNA chip having discriminating probe and amplicon probe immobilized thereon and DNA chip used therein |
| 06/30/2005 | US20050142592 Nucleotide sequences coding proteins for use in diagnosis and treatment of tumors; prostate cancer antigen diagnostic marker 1 (PCADM-1) |
| 06/30/2005 | US20050142590 Diagnosing or monitoring a lysosomal storage disease in a patient by measuring the level of at least one saposin in a tissue sample, the level providing an indication of the presence or absence or extent of the disorder in the patient |
| 06/30/2005 | US20050142580 Methods and probes for diagnosing a gynaecological condition |
| 06/30/2005 | US20050142579 Method for correcting the influence of intensity distribution (shading) of a light source (excitation light) in the scan-less type biochip reader in which a wide biochip range is measured simultaneously with a plurality of light beams |
| 06/30/2005 | US20050142573 Gene segregation and biological sample classification methods |
| 06/30/2005 | US20050142569 Using inflammatory marker gene expression to diagnose arthritis |
| 06/30/2005 | US20050142568 Kit for screening for an apoptosis modulator; an isolated cell death-related nuclease (CRN)polypeptide or fragment, polynucleotide encoding fragment, and/or orthologs; medical diagnosis; genetic engineering and expression; hybridization |
| 06/30/2005 | US20050142567 Composite organic-inorganic nanoparticles and methods for use thereof |
| 06/30/2005 | US20050142566 Sperm-specific cation channel, catSper2, and uses therefor |
| 06/30/2005 | US20050142563 Materials, methods, and kits for reducing nonspecific binding of molecules to a surface |
| 06/30/2005 | US20050142561 Intracellular signaling pathways in diabetic subjects |
| 06/30/2005 | US20050142557 Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
| 06/30/2005 | US20050142552 Susceptibility locus for schizophrenia |
| 06/30/2005 | US20050142551 Fabrication of a high resolution biological molecule detection device with aluminum electrical conductors |
| 06/30/2005 | US20050142549 Reading, detection or quantification method, hybrids or complexes used in said method and the biochip using same |
| 06/30/2005 | US20050142548 Allelic variants of grp50 |
| 06/30/2005 | US20050142547 Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia |
| 06/30/2005 | US20050142546 Assays for identifying modulators of rhomboid polypeptides |
| 06/30/2005 | US20050142544 A genotype is considered as a DNA based link between the situations of the combination, then used in a further consideration, including the review of possible matches between that genotype and a collection of genotype records; genotypes are ranked within the combined set or evaluation |
| 06/30/2005 | US20050142543 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction |
| 06/30/2005 | US20050142541 Antibodies for oncogenic strains of HPV and methods of their use |
| 06/30/2005 | US20050142537 System and method for rapid detection of metabolic deviations of a biological sample |
| 06/30/2005 | US20050142533 Compositions and methods for promoting nerve regeneration |
| 06/30/2005 | US20050142296 Substrates and compounds bonded thereto |
| 06/30/2005 | US20050142259 Adiabatically increasing temperature; retaining raw meat color, texture and flavor characteristics |
| 06/30/2005 | US20050142149 Virulence genes and proteins, and their use |
| 06/30/2005 | US20050142146 Vaccine; against Chlamydia pneumonia; therapy, prevention of infections, |
| 06/30/2005 | US20050142144 Epitope sequences |
| 06/30/2005 | US20050142140 Immunoadhesin comprising a glycoprotein VI domain |
| 06/30/2005 | US20050142138 Endothelial cell expression patterns |
| 06/30/2005 | US20050142132 Prevention and treatment of amyloidogenic disease |
| 06/30/2005 | US20050142102 Administering a hematopoietic growth factor such as granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor to a mammal; providing neuroprotection to the neural cells involved or to induce neurogenesis to recover from neuronal loss |
| 06/30/2005 | US20050142068 Retinal toxicity screening methods |
| 06/30/2005 | US20050142067 Zintrodes, multitrodes and uses thereof |
| 06/30/2005 | US20050142065 Administering test compound to a diabetes mellitus model non-human mammal such as a rat; selecting compound that causes a decrease in a glycated hemoglobin value after administration; drug screening |
| 06/30/2005 | US20050142064 Administering test drug infected with adenovirus used as a vector and engineered by incorporating a detectable reporter gene and having human PXR binding regions falling within an untranslated region of a human CY3A gene; genetic engineering and expression; gene therapy; drug screening |
| 06/30/2005 | US20050142063 Detect low frequency surface changes utilizing modified microspheres; exposing surface; microspheres selectively adhere to any targeted surface marker; dislodging adherent microparticles with folic acid; mouthwash for oral cancer detection |
| 06/30/2005 | US20050142062 Novel method of diagnosing and treating gliomas |
| 06/30/2005 | US20050142033 bioassay modules having an array of multiwells plates with integrated electrodes, used to measure luminescence |
| 06/30/2005 | US20050142032 determining coagulation parameters in blood by converting fluorescently labelled thrombin substrate in multicompartments to form fluorescent indicators, then detecting using optical methods |
| 06/30/2005 | US20050142031 Sample testing device with funnel collector |
| 06/30/2005 | US20050142030 Chemical sensors based on metal nanoparticle encapsulated by mixed ligand and sensor array |
| 06/30/2005 | US20050142029 analysis apparatus formed by providing porous membrane comprising materials that enable capillary movement of liquids, and adhering nonabsorbent media to detectors |
| 06/30/2005 | US20050142028 Brush-like structured surface of poly(ethylene oxide) having elevated density |
| 06/30/2005 | US20050141668 Olfactory method for assessing quantitative and qualitative odour characteristic in an airstream |
| 06/30/2005 | US20050141592 Test element for analyzing sample material |